Why is Parmax Pharma falling/rising?

As of 09-Jul, Parmax Pharma Ltd's stock price is currently flat at 42.00, with no change in percentage terms. The stock has shown a strong performance over the past week, gaining 10.96%, and has also increased by 6.63% over the past month. However, it has a negative year-to-date return of 5.08%. Today's price summary indicates that the stock is performing in line with its sector, but it is trading higher than its 5-day and 20-day moving averages while being lower than its 50-day, 100-day, and 200-day moving averages. Despite positive results in the last three consecutive quarters and a significant year-over-year return of 24.74%, the stock faces challenges due to a negative book value and weak long-term fundamentals, including poor growth in net sales and operating profit.
In the broader market context, Parmax Pharma's recent short-term performance significantly outpaces the benchmark Sensex, which has only increased by 0.15% over the past week and 1.32% over the past month. While the stock has demonstrated strong returns over the past year compared to the market, the decline in investor participation, as evidenced by a 52.38% drop in delivery volume, raises concerns about its liquidity and ongoing interest from investors. The combination of positive short-term performance and underlying fundamental weaknesses suggests that while the stock may be rising in the short term, it faces potential risks that could impact its future performance.